Evidence map›Paper›PMID 35893816›Full record

ArticleVaccines2022

Acceptance Rates of COVID-19 Vaccine Highlight the Need for Targeted Public Health Interventions.

Vered Shkalim Zemer, Zachi Grossman, Herman Avner Cohen, Moshe Hoshen, Maya Gerstein, Noga Yosef, Moriya Cohen, Shai Ashkenazi

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Vered Shkalim ZemerDan-Petach Tikva District, Clalit Health Services, Petach Tikva 4972339, Israel.
Zachi GrossmanAdelson School of Medicine, Ariel University, Ariel 4070000, Israel.
Herman Avner CohenSackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Moshe HoshenDan-Petach Tikva District, Clalit Health Services, Petach Tikva 4972339, Israel.
Maya GersteinAdelson School of Medicine, Ariel University, Ariel 4070000, Israel.
Noga YosefDan-Petach Tikva District, Clalit Health Services, Petach Tikva 4972339, Israel.
Moriya CohenMicrobiolog Unit, Ariel University, Ariel 4070000, Israel.
Shai AshkenaziAdelson School of Medicine, Ariel University, Ariel 4070000, Israel.ORCID 0000-0001-7244-0679
Ariel University · ILTel Aviv University · ILClalit Health Services · ILJerusalem College of Technology · IL

Funding

grant from the Ariel University-Clalit Health Services Research Foundation RA2100000303
6 · The paper itself

Abstract

We aimed to examine rates of COVID-19 vaccination to elucidate the need for targeted public health interventions. We retrospectively reviewed the electronic medical files of all adults registered in a central district in Israel from 1 January 2021 to 31 March 2022. The population was characterized by vaccination status against COVID-19 and the number of doses received. Univariate and multivariable analyses were used to identify predictors of low vaccination rates that required targeted interventions. Of the 246,543 subjects included in the study, 207,911 (84.3%) were vaccinated. The minority groups of ultra-Orthodox Jews and Arabs had lower vaccination rates than the non-ultra-Orthodox Jews (68.7%, 80.5% and 87.7%, respectively, p < 0.001). Adults of low socioeconomic status (SES) had lower vaccination rates compared to those of high SES (74.4% vs. 90.8%, p < 0.001). Adults aged 20−59 years had a lower vaccination rate than those ≥60 years (80.0% vs. 92.1%, p < 0.0001). Multivariate analysis identified five independent variables that were significantly (p < 0.001) associated with low vaccination rates: minority groups of the ultra-Orthodox sector and Arab population, and underlying conditions of asthma, smoking and diabetes mellitus (odds ratios: 0.484, 0.453, 0.843, 0.901 and 0.929, respectively). Specific targeted public health interventions towards these subpopulations with significantly lower rates of vaccination are suggested.

Indexed as

adultscomorbidityCOVID-19COVID-19 vaccinevaccine hesitancy

Identifiers

PMID35893816
PMCPMC9331185
OpenAlexW4287220174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.